Anna Pavala Sindhooram, a novel hypolipidemic agent reduces phospholipid levels in atherosclerosis

Anna Pavala Sindhooram (APS) was investigated in rabbits during atherosclerosis. Changes in the metabolism of plasma and aortic phospholipids were studied by fractionation into individual lipids by tlc and following the incorporation of radiolabel from 14C-acetate into phospholipids. In these studies APS was found to lower the levels of plasma lecithin and aortic sphingomyelin. The effect of APS on plasma lecithin could be partly attributed to its action on synthesis from acetate while synthesis does not account for the effect observed in aortic sphingomyelin levels.